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TO THE EDITOR
Cutis laxa (CL) is a heterogeneous group
of disorders characterized by loose,
redundant, inelastic, or prematurely
wrinkled skin (Berk et al., 2012; Uitto
et al., 2013). Several inherited forms
of CL have been identified (Urban and
Davis, 2014), with nine causative genes
known to date (ALDH18A1, ATP6V0A2,
ATP7A, EFEMP2/FBLN4, ELN, FBLN5,
LTBP4, PYCR1, RIN2). A shared feature
of all types of inherited CL is a reduced
or abnormal deposition of elastic fibers
in the skin and other tissues (Berk
et al., 2012). The consequences of
this disorder for the biomechanics of
the skin has received little attention
(Grahame and Beighton, 1971). Such
studies are essential for a fundamental
understanding of the contribution of
elastic fibers to the mechanical proper-
ties of the skin, and for an improved,
objective diagnosis of CL.
In the present study, 118 participating
controls and 17 CL patients were inclu-
ded with informed, written consent. The
same control cohort was used in a
concurrent study on the mechanical
properties of the skin in Williams–
Beuren syndrome (Kozel et al., 2014).
Table 1. Demography and elasticity parameters in the participants
Controls (n¼ 118) Patients (n¼ 17) P-value
Age 33.22±1.58 29.21±5.47 0.490a
Gender (male %) 37.3% 35.3% 0.874b
E (MPa) 11.61±0.15 7.85±0.60 o0.0001a
Retraction time (ms) 622.82±21.20 1,152.82±211.21 0.024a
VE (MPa) 5.35±0.14 2.51±0.32 o0.0001a
Abbreviations: E, elastic modulus; VE, viscoelastic modulus.
Continuous variables: mean±standard error of mean.
aIndependent t-test.
bChi-square test.
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Abbreviations: ADCL, autosomal dominant cutis laxa; CL, cutis laxa; E, elastic modulus; ROC, receiver
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The IRB committees at the Washington
University School of Medicine and the
University of Pittsburgh approved the
studies. Age and sex were not signifi-
cantly different between cases and
controls (Table 1). The CL group com-
prised individuals diagnosed with CL
based on physical examination and
medical history. Eight individuals of
the CL group were positive for mutations
in known CL genes, with LTBP4 muta-
tions in two, ELN mutations in three,
and ATP6V0A2 mutations in three
patients (Supplementary Table S1
online). In addition, we included nine
patients with unknown mutational status
(Supplementary Table S2 online): three
individuals with congenital and six sub-
jects with late-onset CL. As skin elasti-
city measurements did not show
consistent differences between CL sub-
groups, we pooled all types of CL into
one case group.
Cases and controls underwent testing
using a DermaLab skin elasticity module,
a suction cup device extensively vali-
dated in previous studies (Pedersen et al.,
2003; Grove et al., 2006; Anthonissen
et al., 2013; Gandanke et al., 2014). The
device applies vacuum to a patch of skin
and measures the pressure difference
(DP) required to raise the skin to a
height of 1.5 mm and the time required
for the skin to return to the original
position (retraction time, RT). The
elastic modulus (E) was calculated from
this pressure difference, assuming uni-
form skin thickness (1 mm). In addition, a
viscoelastic modulus (VE) was computed
using E and RT as variables (Supple-
mentary Materials and Methods online).
Cases had significantly lower E,
higher RT, and lower VE (all Po0.05)
than controls (Supplementary Figure S1
online, Table 1). In controls, RT and VE
were significantly correlated with age,
but E was not (Supplementary Table S3
online). In cases, VE was marginally
correlated with age (Supplementary
Table S3 online). Multivariate logistic
regression analysis revealed that age
(P¼ 0.005, OR: 1.21, 95% CI: 1.06–
1.37), VE (P¼0.002, OR: 16.39, 95%
CI: 2.85–95.18), and E (P¼0.043, OR:
3.55, 95% CI: 1.04–12.15) were signifi-
cant predictors of disease status. VE was
the strongest predictor and one unit
reduction in VE increased the odds of
CL 16.39-fold.
We analyzed the receiver operating
characteristic (ROC) to evaluate the
utility of E, RT and VE as predictors.
Of the three, VE performed best, with
ROC area under curve (AUC) reaching
0.908 when applied to the entire study
population (Figure 1a). Restricting
the analysis to individuals younger
than 47 years (bottom 75th percentile
of the control group) yielded some
improvement in the AUC (¼0.964,
Supplementary Figure S2 online).
We next evaluated if additional vari-
ables improved on VE only as diagnostic
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Figure 1. Receiver operating characteristic (ROC) analysis of biomechanical variables and viscoelastic
modulus (VE) in relation to the causative gene mutation. (a) VE is more effective than elastic modulus (E)
or retraction time (RT) in differentiating cases from controls as indicated by ROC curves. (b) Composite
variables under Model 1 (AgeþVEþ E) perform better than Model 2 (AgeþVE). (c) VE values of
individuals with known gene mutations are identified by red tie-lines. Controls are represented by magenta
dots and CL cases by green dots. Linear regression lines are shown in each group (cases: green,
controls: magenta). Note that one individual with ATP6V0A2-related CL had similar age and VE data
to another participant with LTBP4-related CL, resulting in overlapping data points. AUC, area
under curve.
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Two models were considered. Model 1
incorporated VE, age, and E, as sug-
gested by the logistic regression model
described above. Model 2 included VE
and age only. Model 1 (AUC¼ 0.992)
performed significantly (P¼0.0026,
ANOVA) better than Model 2
(AUC¼0.958) in distinguishing cases
from controls (Figure 1b).
The performance of a model on the
same data that was used to fit that
model can give an overly optimistic
measure of performance. To test if such
overfitting had occurred, cross-valida-
tion tests were performed. As the cross-
validation, on average, resulted in only
a modest decrease in AUC values
(Supplementary Table S4 online), over-
fitting was not a major issue in this
analysis, and similar sensitivity and
specificity values can be expected in
future replication studies to our present
results.
A diagnostic variable (D) can be
calculated from the ROC analysis using
the following device-specific formula:
D¼  27.570þ 0.187Ageþ2.795
VEþ1.267 E, where Age is measured
in years, and E and VE are measured in
MPa units. If an individual satisfies the
inequality Do2.538, the probability
of the individual having CL is 99.2%.
This cutoff value of D distinguishes
cases from controls with 100% specifi-
city and 91.5% sensitivity, supporting
the use of the DermaLab device for the
objective, specific, and sensitive diag-
nosis of CL in future studies.
The skin was visually loose in indivi-
duals with CL and decreased VE values
(Supplementary Figure S3 online).
Although there was insufficient number
of individuals within each type of inher-
ited CL to allow for subgroup analysis,
individuals with autosomal dominant
CL (ADCL) caused by ELN mutations
showed the greatest degree of variation
in VE (Figure 1b) compared to indivi-
duals with other mutations, consistent
with previous reports of variable expres-
sion of the skin phenotype in ADCL
patients (Szabo et al., 2006).
Our studies show significant reduc-
tion of E and VE, and significant
increase of the RT of the skin of CL
patients irrespective of the etiology of
the disease. Individuals with acquired or
late-onset CL had similar reductions in
VE compared to controls as individuals
with ELN, LTBP4 or ATP6V0A2 muta-
tions, suggesting that the disruption of
elastic fibers leads to similar biomecha-
nical alterations independent of the
precise molecular disease mechanisms.
VE showed significant inverse correla-
tion with age in both CL and control
individuals, but in controls the decline
started from a higher level and was thus
steeper. Therefore, VE appears to be a
good measure of biomechanical aging
of the skin, and our observations suggest
that CL results in similar changes in skin
mechanics to aging. VE also offers the
best specificity and sensitivity in distin-
guishing cases from controls among the
individual variables measured in our
study.
To date, only one study investigated
the mechanics of the skin in CL
(Grahame and Beighton, 1971). As this
early report had few cases and controls
(6 each), and only measured E but not
retraction, it did not find significant
difference between cases and controls.
In contrast, the present report demon-
strates the utility of biomechanical
measurements in CL.
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